Adherence to pharmacotherapy improves school performance in children with rhinitis and asthma
Main Article Content
Keywords
Allergy, Learning, Absenteeism
Abstract
Background: Adherence to pharmacotherapy reduces symptoms of asthma and rhinitis, however, little is known of its impact on school performance.
Objective: To evaluate the impact of pharmacotherapy in absenteeism and school performance in a child population.
Methods: A cross-sectional study, carried out in eight schools. All participants and their parents were given a questionnaire assessing parameters related to respiratory diseases and pharmacotherapy. Data on school performance was obtained from the academic history of each child who participated in the study. Adherence to pharmacotherapy was classified as a correct use of therapy for more than five days per week.
Results: 1109 children agreed to participate. Students were divided into two groups: symptomatic (36%) and asymptomatic (63%). The symptomatic group had a higher frequency of school absenteeism (1 vs. 3.1 days/year/patient p < 0.01) and lower academic performance (failed: 20% vs. 33% p < 0.01). After dividing the symptomatic group between adherents and non-adherents to the pharmacotherapy, the group of adherents had a similar school performance to the asymptomatic group and it was significantly different from the no-adherent group.
Conclusion: Respiratory symptoms are associated with poor school performance and with an increase in school absenteeism, but adherence to pharmacotherapy can reduce these negative impacts in children.
References
2. Vergara C, Caraballo L. Asthma mortality in Columbia. Ann Allergy Asthma Immunol. 1998;80:55-60.
3. Neffen H, Baena-Cagnani CE, Malka S, Sole D, Sepulveda R, Caraballo L, et al. Asthma mortality in Latin America. J Investig Allergol Clin Immunol. 1997;7:249-53.
4. Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med. 2006;355:2226-35.
5. Anandan C, Nurmatov U, van Schayck O, Sheikh A. Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy. 2010;65:152-67.
6. Fasce L, Tosca MA, Baroffio M, Olcese R, Ciprandi G. Atopy in wheezing infants always starts with monosensitization. Allergy Asthma Proc. 2007;28:449-53.
7. Yepes-Núnez ˜ JJ, Gómez C, Espinoza Y, Cardona R. The impact of subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus on the quality of life of patients with allergic rhinitis and asthma. Biomedica. 2014;34:282-90.
8. Meltzer EO, Gross GN, Katial R, Storms WW. Allergic rhinitis substantially impacts patient quality of life: findings from the Nasal Allergy Survey Assessing Limitations. J Fam Pract. 2012;61 Suppl.:S5-10.
9. Jáuregui I, Mullol J, Dávila I, Ferrer M, Bartra J, del Cuvillo A, et al. Allergic rhinitis and school performance. J Investig Allergol Clin Immunol. 2009;19 Suppl. 1:32-9.
10. Shedden A. Impact of nasal congestion on quality of life and work productivity in allergic rhinitis: findings from a large online survey. Treat Respir Med. 2005;4:439-46.
11. Bro˙zek JL, Bousquet J, Agache I, Agarwal A, Bachert C, BosnicAnticevich S, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017.
12. Sánchez J, Estarita J, Salemi C. Rhinitis and asthma as a cause of absenteeism and poor work/school performance in a population from Latin-American tropic. Rev Alerg Mex. 2016;63:32-40.
13. Baiardini I, Braido F, Tarantini F, Porcu A, Bonini S, Bousquet PJ, et al. ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. Allergy. 2008;63:660-9.
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83.
15. Velástegui C, Pérez-Canto P, Zárate V, Arenas D, Salinas P, Moreno G, et al. Impact of asthma among primary attention children. Rev Med Chil. 2010;138:205-12.
16. Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M. Economic burden indirect costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population. J Manag Care Pharm. 2008;14:176-85.
17. de la Hoz Caballer B, Rodríguez M, Fraj J, Cerecedo I, AntolínAmérigo D, Colás C. Allergic rhinitis and its impact on work productivity in primary care practice and a comparison with other common diseases: the Cross-sectional study to evAluate work Productivity in allergic Rhinitis compared with other common diseases (CAPRI) study. Am J Rhinol Allergy. 2012;26:390-4.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.